India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages Multiple Principal Investigator (Multi-PD/PI) applications from United States (U.S.)-based institutions with an Indian institution partner to establish bilateral collaborations that will advance science and technology important to understanding, preventing, and treating blinding eye diseases, visual disorders, and their complications.

Applications are encouraged from organizations/institutions that propose to conduct research on the basic biology and/or genetics of ophthalmic diseases through collaborations with Indian investigators on the following: diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pigmentosa, including rare and genetic diseases such as congenital cataracts, as well as other eye conditions such as ocular inflammation/uveitis, refractive error, low vision, and corneal injury. Basic, translational, or epidemiological research may be proposed. Clinical trials will not be supported under this FOA.

Application Due Date(s): November 8, 2021; November 8, 2022; November 8, 2023

PAR-21-249 Expiration Date November 09, 2023

Agency Website

Eligibility Requirements

This FOA requires that the collaboration between the U.S. and Indian research teams be submitted as a Multiple Principal Investigator (Multi-PD/PI) application with both of the lead scientists from each country as the PD/PI.



Amount Description

Application budgets are limited to $250,000 annual direct cost, but need to reflect the actual needs of the proposed project.
 The project period is limited to three years.

Funding Type





Engineering and Physical Sciences
International Opportunities
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

November 8, 2023